Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocilizumab Post Allograft Nephrectomy (RAIPONS)
NCT04779957Phase 2Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Oct 2021
- Primary completion
- Aug 2024
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 2 trial of tocilizumab in alloimmunization, sponsored by Centre hospitalier universitaire de Toulouse. Started Oct 2021; status: completed.
02
Drugs
tocilizumab
03
Conditions
alloimmunization
Beyond the preview
Go deeper on NCT04779957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04779957.